The role of patient-based treatment planning in peptide receptor radionuclide therapy

被引：0
|
作者：
Deni Hardiansyah
Christian Maass
Ali Asgar Attarwala
Berthold Müller
Peter Kletting
Felix M. Mottaghy
Gerhard Glatting
机构：
[1] Heidelberg University,Medical Radiation Physics/Radiation Protection, Universitätsmedizin Mannheim, Medical Faculty Mannheim
[2] Universitätsmedizin Mannheim,Department of Radiation Oncology
[3] Medical Faculty Mannheim,Klinik für Nuklearmedizin
[4] Heidelberg University,Klinik für Nuklearmedizin
[5] University Hospital,Department of Nuclear Medicine
[6] RWTH Aachen University,undefined
[7] Universität Ulm,undefined
[8] Maastricht University Medical Center (MUMC+),undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2016年 / 43卷
关键词：
PRRT; PBPK modeling; Treatment planning; PET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：871 / 880
页数：9
相关论文
共 50 条
  • [31] Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in children
    Foster, Jennifer H.
    Sher, Andrew
    Seghers, Victor
    Poston, Jay
    Wells, Donald
    Delpassand, Ebrahim S.
    Potter, Samara
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [32] Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors: is there a role for FDG-PET in predicting response to treatment?
    Severi, S.
    Sansovini, M.
    Bodei, L.
    Milandri, C.
    Ambrosetti, A.
    Galassi, R.
    Annunziata, F.
    Scarpi, E.
    Monti, M.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S116 - S116
  • [33] Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review
    Chalkia, M. T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    Round, W. H.
    Efstathopoulos, E. P.
    Nikiforidis, G. C.
    AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE, 2015, 38 (01) : 7 - 22
  • [34] Multimodality Imaging in a Patient With Adrenocortical Carcinoma Leading to Peptide Receptor Radionuclide Therapy
    Andersen, Kim Francis
    Mellemgaard, Anders
    Hendel, Helle Westergren
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (08) : 543 - 548
  • [35] First Experience Using Peptide Receptor Radionuclide Therapy in a Patient With Urothelial Carcinoma
    Putzer, Daniel
    Gabriel, Michael
    Prommegger, Rupert
    Kendler, Dorota
    Virgolini, Irene Johanna
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (10) : E404 - E406
  • [36] Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review
    M. T. Chalkia
    A. P. Stefanoyiannis
    S. N. Chatziioannou
    W. H. Round
    E. P. Efstathopoulos
    G. C. Nikiforidis
    Australasian Physical & Engineering Sciences in Medicine, 2015, 38 : 7 - 22
  • [37] Acanthosis nigricans in a patient with metastatic insulinoma post peptide receptor radionuclide therapy
    Yun, Jenny S. W.
    McCormack, Chris
    Goh, Michelle
    Chiang, Cherie
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2022, 2022
  • [38] The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy
    Yordanova, Anna
    Wicharz, Marcel M.
    Mayer, Karin
    Brossart, Peter
    Gonzalez-Carmona, Maria A.
    Strassburg, Christian P.
    Fimmers, Rolf
    Essler, Markus
    Ahmadzadehfar, Hojjat
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4672 - 4679
  • [39] Time interval, number of cycles and radionuclide choice in PRRT (Peptide Receptor Radionuclide Therapy): radiobiological considerations to guide therapy planning
    Cremonesi, M.
    Bodei, L.
    Botta, F.
    Di Dia, A.
    Ferrari, M.
    De Cicco, C.
    Chinol, M.
    Pedroli, G.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S218 - S218
  • [40] Peptide receptor radionuclide therapy of neuroendocrine tumours
    Brabander, Tessa
    Teunissen, Jaap J. M.
    Van Eijck, Casper H. J.
    Franssen, Gaston J. H.
    Feelders, Richard A.
    de Herder, Wouter W.
    Kwekkeboom, Dik J.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (01) : 103 - 114
12345